Addendum AgreementAddendum Agreement • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations
This Addendum Agreement is made this 28 day of December 2000, between Bioglan Pharma PLC of 5, Hunting Gate, Hitchin, Hertfordshire SG4 OTJ (“Bioglan”) and Jagotec AG of Eptingerstrasse 51, CH-4132 Muttenz, Switzerland (“Jago”).
THIRD AMENDMENT TO DISTRIBUTION AGREEMENTDistribution Agreement • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Third Amendment to Distribution Agreement (this “Amendment”), dated as of April 13th, 2004, is by and between Par Pharmaceutical, Inc., a Delaware corporation (successor by merger to Par Pharmaceutical, Inc., a New Jersey corporation) (“Par”), and Quintiles Ireland Limited, a company incorporated in the Republics of Ireland (“Quintiles”).
ContractLicense and Manufacturing Agreement • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • England and Wales
Confidential portions of this document have been omitted and filed separately with the Commission. The omitted portions have been marked as follows: “***”.
SECOND AMENDMENT TO DISTRIBUTION AGREEMENT and FIRST AMENDMENT TO ASSIGNMENT OF DISTRIBUTION AGREEMENTDistribution Agreement • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Second Amendment to the Distribution Agreement and First Amendment to the Assignment of Distribution Agreement (this “Amendment”), dated as of September 11, 2003, is by and between Par Pharmaceutical, Inc., a Delaware corporation (successor by merger to Par Pharmaceutical, Inc., a New Jersey corporation) (“Par”), and Quintiles Ireland Limited, a company incorporated in the Republic of Ireland (“Quintiles”).
CONSENT AND AGREEMENTDistribution Agreement • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations
This Consent and Agreement (this “Agreement”) is entered into as of July 9, 2004 between Par Pharmaceutical, Inc. (“Par”) and Quintiles Ireland Limited (“QIreland”).
DEED OF CONSENT AND NOVATIONDeed of Consent and Novation • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations
This Deed of Consent and Novation (this “Deed”) is entered into as of August 4, 2004 among Jagotec AG (“Jagotec”), Quintiles Transnational Corp. (“Quintiles”), Quintiles Ireland Limited, an affiliate of Quintiles (“QIreland”), Bradley Pharmaceuticals, Inc. (“Bradley”) and BDY Acquisition Corp. (the “Buyer”), a wholly-owned subsidiary of Bradley.
Second AddendumAddendum Agreement • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations
This Addendum Agreement is made this day of December 2001, between Bioglan Pharma PLC of 5, Hunting Gate, Hitchin, Hertfordshire SG4 DTJ (“Bioglan”) and Jagotec AG of Eptingerstrasse 51, CH-4132 Murtenz, Switzerland (“Jago”) and Quintiles Ireland Limited of East Point Business Park, Fairview, Dublin 3, Ireland (“Quintiles”).
DISTRIBUTION AGREEMENTDistribution Agreement • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AGREEMENT made as of this 27th day of December, 2000 (the “Effective Date”), by and between Par Pharmaceutical, Inc., a New Jersey corporation, with offices at One Ram Ridge Road, Spring Valley, New York 10977 (hereinafter referred to as “Par”) and Bioglan Pharma, Inc., a Delaware corporation, with offices at 7 Great Valley Parkway, Suite 301, Malvern, PA 19355 (hereinafter referred to as “Bioglan”).
ASSIGNMENT OF DISTRIBUTION AGREEMENTDistribution Agreement • November 9th, 2004 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations
This ASSIGNMENT OF DISTRIBUTION AGREEMENT (this “Assignment”) is dated and effective as of the Effective Time (as defined below) by and among Par Pharmaceutical, Inc, a New Jersey corporation (“Par”), Bioglan Pharma, Inc., a Delaware corporation (“Bioglan”), and Quintiles Ireland Limited, a company incorporated in the Republic of Ireland (“Quintiles”).
